autoevolution
 

Mercedes Benz Raffle Vehicles to Benefit the 2011 Leukemia Ball

The North American division of Mercedes Benz announced today that its Washington area dealers have come together to become the Raffle Presenting Sponsor for the fifteenth year in support of The National Capital Area Chapter of The Leukemia & Lymphoma Society's Annual Leukemia Ball in 2011.

The company has announced that it is donating a 2011 Mercedes-Benz E350 Cabriolet (Grand Prize; MSRP: $57,725) and a 2011 C300 Sport Sedan (First Prize; MSRP: $34,865), with all proceeds from this raffle set to go directly towards funding the LLS mission to cure blood cancers.

Raffle tickets are on-sale now for $100. The drawing will take place during the 2011 Leukemia Ball on March 12 at the Washington Convention Center – and only 6,000 tickets are printed.

"On behalf of the Washington area's Mercedes-Benz dealers, we are proud to be a part of one of the most successful charitable events in Washington," said Pete Collins, Mercedes-Benz USA Northeast Region Area Manager. "It is of the utmost importance to our dealers to support local causes within the community that our customers care about."

This year’s Leukemia Ball takes place on March 12, 2011 at the Walter E. Washington Convention Center. As for the two vehicles donated for the raffle, the 2011 Mercedes-Benz E350 Cabriolet packs a 268-hp, 3.5-liter V-6 engine, with standard features including Attention Assist, Pre-Safe, Brake Assist, Distronic Plus with Pre-Safe Brake, Parktronic with parking guidance and Adaptive High Beam Assist.

As for the 2011 Mercedes-Benz C300 Sport Sedan, the model is powered by a 228-horsepower 3.0-liter V-6 engine, and comes with Electronic stability program, LED daytime running lamps, front passenger Occupant Classification System (OCS), 4-wheel anti-lock disc brake system (ABS) and Brake Assist.
If you liked the article, please follow us:  Google News icon Google News Youtube Instagram
 

Would you like AUTOEVOLUTION to send you notifications?

You will only receive our top stories